Good Catch! How to Identify and Manage Common Antiretroviral Drug Interactions

Presenter: Katherine Lepik
Location: Conference Room 6, Providence Building Level 1, St. Paul’s Hospital
Date: Wednesday, February 27, 2019
Kathy Lepik is the Research Coordinator of the BC Centre for Excellence in HIV/AIDS Pharmacovigilance Initiative, where she is responsible for tracking, analyzing, and following up on adverse reactions and drug interactions to antiretroviral drugs. Her work also involves initiating measures to improve patient safety and managing research projects. Kathy is also a clinical pharmacist providing patient care through the St Paul’s Hospital Ambulatory Pharmacy.
Credit: This 1-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the BC Chapter for up to 1 Mainpro+ credits.
Registration: Eventbrite - Forefront Lectures


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • February 27, 2019 12:00
End Date
  • February 27, 2019 13:00
Email
education@bccfe.ca
Event Category
Calendar of Events
Click here for the Calendar of Events
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search